A Study of ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma

Clinical trial NCT02914938 · TERMINATED

Trial details

NCT number: NCT02914938
Sponsor: MEI Pharma, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)Follicular Lymphoma (FL)Marginal Zone B Cell Lymphoma Diffuse Large B-cell Lymphoma (DLBCL)High Grade Non-Hodgkin's Lymphoma Mantle Cell Lymphoma (MCL)

Start date: 2016-10-01
Primary completion: 2023-03-29
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.